BioOra
PrivateLast Round
Series A
Oct 2, 2025
Est. Valuation
$34.5M
Total Funding Raised
$9.16M
Momentum Score
50 /100
Company Overview
BioOra is a biotechnology company that develops and manufactures third-generation CAR T-cell therapies for cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Smart Manufacturing
Business Model
B2G
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioOra Comps
Public and private peers based on sector, stage, and business model.
BioOra Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 2, 2025 | ||||
| VC Round | Apr 1, 2025 | ||||
| VC Round | Nov 22, 2024 | ||||
| Seed | Nov 1, 2022 | ||||
| Debt | Sep 23, 2021 |
BioOra Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Callaghan Innovation | Debt, Seed |
| Bridgewest Ventures | Series A, VC Round, Debt, Seed |
| Mainland Angel Investors | VC Round |
| Booster Innovation Fund | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 14, 2026
Developing CAR-T therapy for children with leukaemia in partnership with Cincinnati Children's.
- Apr 14, 2026
Collaborating with Cincinnati Children's Hospital on CAR-T therapy for leukaemia.
BioOra Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BioOra's valuation, stock price, and market status.
